The Latest Analyst Ratings For Insulet
Portfolio Pulse from Benzinga Insights
Five analysts have recently evaluated Insulet (NASDAQ:PODD), with a mix of bullish and bearish perspectives. The average 12-month price target has increased by 1.6% to $232.4. Key analysts have adjusted their ratings and price targets, reflecting evolving market conditions and company performance. Insulet has shown strong financial metrics, including a 10.6% revenue growth rate, a 38.61% net margin, a 21.08% ROE, and a 6.85% ROA, but has a higher debt-to-equity ratio of 1.4.
August 12, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed views on Insulet (NASDAQ:PODD) with an average 12-month price target of $232.4, up 1.6% from the previous target. The company has strong financial metrics but a high debt-to-equity ratio.
The increase in the average price target and strong financial metrics suggest a positive short-term impact on Insulet's stock price. However, the high debt-to-equity ratio introduces some financial risk.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100